диссертации / 4
.pdf131
109. Effects of Fexofenadine, Diphenhydramine, and Alcohol on driving Performance. A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator / J.M. Weiler [et al.] // Annals of Internal Medicine. – 2000. – Vol. 132. - № 5. – p. 405 – 407.
110.Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria / E. Nettis [et al.] // J. Allergy Clin. Immunol. – 2003. – 112. – p. 212–213.
111.Emanuel M.B. Histamine and the antiallergic antihistamines: a history of their discoveries/M.B. Emanuel // Clinical and Experimental Allergy. - 1999. - vol. 29. - sup. 3. - p. 1 - 11.
112.Engin B Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria / B. Engin, M. Ozdemir // J. Eur. Acad. Dermatol. Venereol. – 2008. – 22. – p. 481 –
486.
113. Epidemiology of urticaria: a representative cross-sectional population survey / T. Zuberbier [et al.] // Clinical and Experimental Dermatology. -2010. – 35. – p. 869 – 873.
114. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test / E. Magen [et al.] // Helicobacter. – 2007. - 12. – p. 567 – 571.
115. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study / Z. Erbagci // J. Allergy Clin. Immunol. – 2002. - 110. – p. 484488.
116.Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine / Marta Ferrer [et al.] // Clin. Drug. Investig. – 2010. - 30 (1). – p. 15 - 34.
117.Factors associated with the development of peanut allergy in childhood / Lack G. [et al.] // N. Engl. J. Med. - 2003. – 348. – p. 977 – 985.
118.Ferrer M. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts / M.
132
Ferrer, I. Ja´uregui, J. Bartra // British Journal of Dermatology. – 2009. – 160. - p. 823 – 827.
119. First M.R. First clinical experience with the new once-daily formulation of tacrolimus / M.R. First // Ther. Drug Monit. – 2008. - 30. – p. 159 – 166.
120.First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990–2005 / A. Sen [et al.] // Aviat. Space. Environ. Med. – 2007. – 78. – p. 514 – 522.
121.Fixed solar urticaria with delayed onset / U. Wessendorf [et al.] // J. Am. Acad. Dermatol. – 2008. – vol. 60, № 4. – p. 695 - 697.
122.Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria / G. Di Lorenzo [et al.] // Int. Arch. Allergy Immunol. – 2005. –
138.– p. 235 – 242.
123.Fromer L. Treatment options for the relief of chronic idiopathic urticaria symptoms / L. Fromer // South Med. J. – 2008. -101. – p. 186 – 192.
124. Functional neuroimaging of |
cognition |
impaired |
by |
a |
classical |
antihistamine, dichlorpheniramine / N. Okamura [et al.] // Br. J. Pharmacol. – 2000.
–129. – p. 115 – 123.
125.Functional assessment of pathogenic IgG subclasses in chronic autoimmune
urticaria / S. Soundararajan [et al.] // J. Allergy Clin. Immunol. – 2005. – 115. - p.
815 - 836.
126.Fusari A. The autologous serum skin test in the follow-up of patients with chronic urticaria / A. Fusari, C. Colangelo, F. Bonifazi // Allergy. – 2005. – 60. – p. 256 – 258.
127.Geevasinga N. Mycophenolate mofetil; a review of indications and use in a large tertiary hospital / N. Geevasinga, L. Wallman, C.H. Katelaris // Iran J. Allergy Asthma Immunol. – 2005. – 4. p. 159-166.
128.Godse K.V. Omalizumab in severe chronic urticaria / K.V. Godse // Indian J. Dermatol. Venereol. Leprol. – 2008. – 74. – p. 157 – 158.
129.Gonthier R. Useful assessment for identifying unsafe driving / R. Gonthier, C. Fabrigoule, A. Domont // Psychol. Neuropsychiatr. Vieil. – 2005. - 3(1). – p. 27 -
133
42.
130. Grattan C.E. The urticaria spectrum: recognition of clinical patterns can help management / C. E. Grattan // Clin. Exp. Dermatol. – 2004. – vol. 29, № 3 – p. 217 – 221.
131.Grattan C. E. H. Aspirin sensitivity and urticaria / C. E. H. Grattan // Clinical and Experimental Dermatology. – 2003. – 28. – p. 123 – 127.
132.Graves J.E. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab and alefacept / J.E. Graves, K. Nunley, M.P. Heffernan // J. Am. Acad. Dermatol. – 2007. – 56. – p. 55 - 79.
133.Greaves M. W. Drug-induced urticaria and angioedema: pathomechanisms and frequencies in a developing Country and in developed Countries / M.W. Greaves, S. H. Hussein // Int. Arch. Allergy Immunol. – 2002. - 128. – p. 1 - 7.
134.Greaves M.W. Pathophysiology of Chronic Urticaria / M. W. Greaves // Int. Arch. Allergy Immunol. – 2002. -127. – p. 3–9.
135.Greenberger P.A. Anaphylactic and anaphylactoid causes of angioedema / P. A. Greenberger // Immunol. Allergy Clin. North. Am. – 2006. – vol. 26, № 4. – p. 753
– 767.
136.Handa S. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria / S. Handa, S. Dogra, B. Kumar // J. Dermatol. Treat. –
2004. – 15. – p. 55 – 57.
137.High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pyloriassociated lipoprotein in chronic urticaria / N. Bakos [et al.] // Allergy. – 2003. – 58. – p. 663 – 667.
138.High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study / F. Siebenhaar et [al.] // J. Allergy Clin. Immunol. - 2009. – 123. – p. 672 - 679.
139.Hindmarch I. An evaluation of effects of high – dose fexofenadine on the central nervous system: a doubleblind, placebo-controlled study in healthy volunteers / I.
134
Hindmarch, Z. Shamsi, S. Kimber // Clin. Exp. Allergy. – 2002. – 32. – p. 133 – 139.
140.Histamine H1 – receptor occupancy and pharmacodinamics of second generation H1 – antihistamines / M. Gillard [et al.] // Inflamm. Res. – 2005. – 54. – p. 367 - 369.
141.HLA Class I and Class II Genotyping in patients with chronic urticaria / Müge Çoban [et al.] // Int. Arch. Allergy Immunol. - 2008. – 147. – p. 135–139.
142.Hönigsmann H. Mechanisms of phototherapy and photochemotherapy for
photodermatoses / H. Hönigsmann // Dermatol. Ther. – 2003. – 16. – p.23 – 27.
143.House dust mite sensitivity is a factor in chronic urticaria / P.A. Mahesh [et al.] // Indian J. Dermatol. Venereol. Leprol. – 2005. - vol 71., № 2. – p. 99 -101.
144.How to assess disease activity in patients with chronic urticaria? / A. Młynek [et
al.] // Allergy. – 2008. – 63. – p. 777 – 780.
145. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride / I. R. Katz [et al.] // J. Am. Geriatr. Soc. – 1998. –
46.– p. 8 – 13.
146.IgE Antithyroid Antibodies in Patients with Hashimoto’s Disease and Chronic
Urticaria / L. B. Concha [et al.] // Allergy and Asthma Proc. – 2004. – 25. – p. 293 – 296.
147. Immune Tolerance to Drugs: Long–Term Tolerability of Nimesulide in Patients with NSAID Hypersensitivity / E. Nettis [et al.] // Immunopharmacology and immunotoxicology. – 2004. -Vol. 26, No. 3. - p. 469 – 480.
148.Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation / G.E.M. Reeves [et al.] // Internal Medicine Journal. - 2004. – 34. – p. 182 - 186.
149.Incremental build-up food challenge – a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study / B. Bunselmeyer [et al.]
//Clinical and Experimental Allergy. – 2008. – 39. – p. 116 – 126.
150.Is Anisakis simplex Responsible for Chronic Urticaria? / Maria Pilar Lo´ pez-Sa´
ez [et al.] // Allergy and Asthma. – 2003. - Vol. 24, No. 5 – p. 339 - 345.
135
151.Is there a role for antileukotrienes in urticaria? / G.D. Lorenzo et al. // Clinical and Experimental Dermatology. – 2006. – vol. 31. - p. 327–334.
152.Jurakić Tončić R. Treatment of chronic urticaria / R. Jurakić Tončić, J. Lipozenčić, B. Marinović // Acta Dermatovenerol. Croat. – 2009. -17(4). – p. 305 –
322.
153.Kaplan A.P. What the first 10,000 patients with chronic urticaria have taught me: A personal journey / A.P. Kaplan // J. Allergy Clin. Immunol. - 2009. 123. – p. 713 - 720.
154.Kessel A. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study / A. Kessel, E. Bamberger, E. Toubi // J. Am. Acad. Dermatol. – 2005. – 52. – p.145 - 148.
155.Khan D. A. Chronic urticaria: Diagnosis and management / D. A. Khan // Allergy and Asthma Proceedings. – 2008. - Vol. 29, No. 5. – p. 439 - 446.
156.Kozel M.M.A. Chronic Urticaria. Aetiology, management and current and future treatment options / Martina M.A. Kozel, Ruth A. Sabroe // Drugs. – 2004. - 64 (22). - p. 2515 - 2536.
157.Kroiss M. The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria / M. Kroiss, T. Vogt, M. Landthaler // Acta Derm. Venereol. - 2000. - 80.
– p. 225.
158. Kurose Y. |
Histamine |
regulates |
food intake through |
modulating |
noradrenaline |
release in |
the paraventricular nucleus / Y. Kurose, |
Y. Terashima |
|
// Brain Res. – 1999. – 828. – p. 115 - 118.
159.Lawlor F. Delayed pressure urticaria / F. Lawlor, A. Kobza Black // Immunol. Allergy Clin. N. Am. 2004. – 24. – p. 247 – 258.
160.Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study/ E. Nettis, M.C. [et al.] // British Journal of Dermatology. – 2006. – 154. – p. 533 – 538.
161.Limsuwan T. Acute Symptoms of drug Hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic Shock / T. Limsuwan, P. Demoly // Med. Clin. – 2010. –
94. – p. 691 – 710.
136
162.Lipozenčić J. Cyclosporine in chronic idiopathic urticaria / J. Lipozenčić, S. Ljubojević // Acta Dermatovenereol. Croat. – 2007. – 15. – p. 50.
163.Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study / N. Cassano [et al.] // Acta Derm. Venereol. – 2005. – 85. – p. 254 – 255.
164.Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria / C. Pereira [et al.] // Eur. Ann. Allergy Clin. Immunol. – 2007. – 39. – p. 237 - 242.
165.Madan V. Systemic cyclosporin and tacrolimus in dermatology / V. Madan, C.E. Griffiths // Dermatol. Ther. – 2007. – 20. – p. 239 – 250.
166.Malhotra S. K. Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria and chronic urticaria / S. K. Malhotra, Vivek Mehta
//Indian J. Dermatol. Venereol. Leprol. – 2008. – 74. – p. 594 – 599.
167.Mamatha G. , Balachandran C. , Smitha P. Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test / George Mamatha, C. Balachandran, Prabhu Smitha // Indian J. Dermatol. Venereol. Leprol. - 2008. – vol. 74, № 2. – p. 105 - 108.
168.Mankad V.S. Omalizumab: other indications and unanswered questions / V.S. Mankad, A.W. Burks // Clin. Rev. Allergy Immunol. – 2005. – 29. – p. 17 – 30.
169.Mateus C. Treatment of chronic idiopathic urticaria unresponsive to type 1
antihistamines in monotherapy / C. Mateus // Ann. Dermatol. Venereol. – 2003. –
130. – p. 129 - 144.
170.Maurer M. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor–patient relation / M. Maurer, J -P. Ortonne, T. Zuberbier // Allergy. –
2009. – 64. – p. 581–588.
171.Maurer M. Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients / M. Maurer, J-P. Ortonne, T. Zuberbier // British Journal of Dermatology. – 2009. – 160. - p. 633–641.
172.Mechanism of action of doxepin in the treatment of chronic urticaria / A. Figueiredo [et al.] // Fundam. Clin. Pharmacol. - 1990. – 4. – p. 147 – 158.
137
173. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases /
J.E. Gach [et al.] // Br. J. Dermatol. – 2001. - 145. – p. 340-343.
174.Middleton’s Allergy: Principles and Practice / N.F. Jr. Adkinson, ed. - 7th ed, - Philadelphia, Pa: Mosby Elsevier, 2008. – 1896 p.
175.Mike E. Histamine and its receptors / E. Mike, Pearson, Robin Ganellin // British Journal of Pharmacology.- 2006. - 147. - p. 127 - 135.
176.Moder K.G. Mycophenolate mofetil: new applications for this immunosuppressant / K.G. Moder //Ann. Allergy, Asthma, Immunol. - 2003. - 90.
–p. 15 – 19.
177.Morison W.L. Solar urticaria due to progesterone compounds in oral contraceptives / W. L. Morison // Photodermatol. Photoimmunol. Photomed. - 2003. – 19. – p. 155 - 156.
178.Mukesh Yadav K. Chronic urticaria and Helicobacter pylori / K. Mukesh Yadav, Jai P. Rishi, S. Nijawan // Indian J Med Sci. – 2008. - vol. 62, No. 4. – p. 157 - 162.
179.Muller. B. A. Urticaria and Angioedema: a practical approach / B. A. Muller //
American family physician. - 2004. - Vol. 69, №5. – p. 1123 – 1128.
180.Najib U., Sheikh J. The spectrum of chronic urticaria / U. Najib, J. Sheikh // Allergy and Astma Proceedings. – 2009. - vol. 30, №1.- p.1 - 10.
181.Nakaji S Membranes for therapeutic apheresis / S. Nakaji, T. Yamamoto // Ther. Apheresis. – 2002. - 6. – p. 267 – 270.
182.Narrowband ultraviolet B photo-therapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study / E. Borzova [et al.] // J. Am. Acad. Dermatol. – 2008. - 59. – p. 752 – 757.
183.NEO-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a doubleblind, randomized, placebo-controlled trial / G.A. Vena [et al.] // J. Am. Acad. Dermatol. – 2006. – 55. – p. 705 - 709.
184.Neuroimaging of histamine H1-receptor occupancy in human brain by
positron emisión tomography (PET): A comparative study of ebastine, a second generation antihistamine, and (+) chlorpheniramine, a classical antihistamine / M. Tagawa [et al.] // Br. J. Clin. Pharmacol. – 2001. - 52. – p. 501 - 509.
138
185. O¨zdemir O. Idiopathic (autoimmune) chronic urticaria / O¨ner O¨zdemir //
Allergy and Asthma Proceedings. – 2006 - vol. 27, No. 5. – p. 431 - 434.
186.Omalizumab as a therapeutic alternative for chronic urticaria / J.L. CallejasRubio [et al.] // Ann. Allergy Asthma Immunol. – 2008. – 101. – p. 556.
187.Ota M. Ice Cream Urticaria / M. Ota, H. Kawasaki, M. Horimoto // The American Journal of Medicine. – 2010, - vol. 123, No 12. – p. 1- 2.
188. |
Pertz H. H. Structure activity relationships of histamine H 1 -receptor agonists |
/ H. H. Pertz, S. Elz, W. Schunak // Med.Chem. – 2004. – 4. – p. 935 – 940. |
|
189. |
Poonawalla T. Urticaria / T. Poonawalla, B. Kelly // Am. J. Clin. Deimatol. – |
2009. – vol.10, №1. – p. 9 - 21.
190.Prevalence and relevance of the positivity of skin prick testing in patients with chronic urticaria / Kanokvalai Kulthanan [et al.] // Journal of Dermatology. – 2008.
– 35. – p. 330 – 335.
191.Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability / S. Buhner [et al.] // Allergy. 2004. – 59. – p. 1118 –
1123.
192.Psychological factors in allergic skin diseases / M. Kiec-Swierczynska [et al.] // Med. Pr. - 2008. – vol. 59, №4. - p. 279 - 285.
193.Psychological status of patients with chronic urticaria / G. Pasaoglu [et al.] // Journal of Dermatology. – 2006. – 33. – p. 765 – 771.
194.Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity / P. Staubach [et al.] // British Journal of Dermatology. – 2006. – 154. - p. 294 – 298.
195.Radiological aid to clinical diagnosis of Schnitzler’s syndrome: multimodality
imaging approach / A. F. Flórez [et al.] // Clin. Rheumatol. – 2008. – 27. – p. 107 –
110.
196.Risk of first-generation H 1 - antihistamines: a GA2LEN position paper/ M. K. Church [et al.] // Allergy. – 2010. - 65. – p. 459 – 466.
197.Risk of first-generation H1-antihistamines: a GALEN position paper / M.K. Church [et al.] //Allergy.- 2010.- 65.- p. 459-466.
139
198.Roger W. Cronic urticaria: mechanisms and treatment / W. Roger // Allergy and Asthma. – 2001. - vol. 22. - № 2. - p. 97-100.
199.Role of Helicobacter pylori infection in the treatment and outcome of chronic urticaria / S. Hellmig [et al.] // Helicobacter. – 2008. - 13. – p. 341 –345.
200.Sadighha A. Relationship between Helicobacter pylori and chronic urticaria / A. Sadighha, R. Shirali, G. Mohaghegh Zahed // Journal European Academy of Dermatology and Venereology. – 2009. – 23. – p. 198 - 199.
201.Sánchez-Borges M. NSAID-Induced Urticaria and Angioedema / M. SánchezBorges, A. Capriles-Hulett, F. Caballero-Fonseca // Am. J. Clin. Dermatol. – 2002.
–vol. 3, № 9. – p. 599 - 607.
202.Sastre J. Ebastine in allergic rhinitis and chronic idiopathic urticaria / J. Sastre // Allergy. – 2008. - 63 (Suppl. 89). – p. 1 – 20.
203.Schnitzler syndrome associated with systemic marginal zone B-cell lymphoma / S. Dalle [et al.] // British Journal of Dermatology. – 2006. – 155. – p. 827 – 829.
204.Schnitzler’s syndrome treated successfully with intravenous
pulsecyclophosphamide / D. Peterlana [et al.] // Scand. J. Rheumatol. - 2005. – 34.
- p. 328 – 330.
205.Schnitzler’s Syndrome: monoclonal gammopathy associated with chronic urticaria / R. Rizzi [et al.] // Acta Haematol. – 2008. - 120. – p. 1 – 4.
206.Sedation with “non-sedating” antihistamines: four prescription-event monitoring studies in general practice / R.D. Mann [et al.] // BMJ. – 2000. -320. – p. 1184 –
1186.
207.Shamsi Z. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers / Z. Shamsi, S. Kimber, I. Hindmarch // Eur. J. Clin. Pharmacol. – 2001.- 56. – p. 865 – 871.
208.Sharpe G.R. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone / G.R. Sharpe, S. Shuster // Br. J. Der-matol. – 1993. – 129. – p. 575 –579.
|
140 |
|
209. Sheikh J. Effect of omalizumab on patients with chronic |
urticaria: issues |
|
with the determination |
of autoimmune urticaria / J. Sheikh |
// Ann. Allergy |
Asthma Immunol. – 2008. |
– 100. – p. 88 - 89. |
|
210.Shipley D. Drug-Induced Urticaria / D. Shipley, A. D. Ormerod // Am. J. Clin. Dermatol. - 2001. – vol. 2, №3. – p. 151 - 158.
211.Simons F. E. Advances in H1-Antihistamines / F. E. Simons // N. Engl. J. Med. –
2004. – 351. – p. 2203 - 2217. |
|
|
212. |
Solar angioedema: an uncommonly recognized condition? / R. F. Rose [et al.] // |
|
Photodermatol., Photoimmunol., Photomed. – 2005. – 21. – p. 226 – 228. |
||
213. |
Solar urticaria successfully treated with |
intravenous immunoglobulins / L. |
Maksimovic [et al.] // Dermatology. – 2009. |
- 218. – p. 252–254. |
|
214. |
Solar urticaria treated successfully with intravenous high-dose immunoglobulin: |
|
a case report / I. Correia [et al.] // Photodermatol. Photoimmunol. Photomed. – 2008. – 24. – p. 330 – 331.
215. Spector S.L. Omalizumab also successful in chronic urticaria / S.L. Spector, R.A.
Tan // J Allergy Clin Immunol. – 2008. – 121. – p.784.
216. Spector S.L. Therapeutic alternatives for chronic urticaria: additional reports
on omalizumab / S. L. Spector, R.A. Tan // Ann. Allergy Asthma Immunol. – 2008.
- 101. – p. 647. |
|
|
217. Successful sulfasalazine treatment |
of severe chronic idiopathic |
urticaria |
associated with pressure urticaria / K. |
Hartmann [et al.] // Acta Derm. Venereol. |
|
– 2001. - 81. - p. 71.
218.Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy / M. Metz [et al.] // Allergy. – 2008. - 63. – p. 247 - 249.
219.Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine / L.Y. McGirt [et al.] // Arch. Dermatol. - 2006. – 142. – p. 1337 –
1342.
220. Successful treatment of solar urticaria with anti-immunoglobulin E therapy / O. Guzelbey [et al.] //Allergy. – 2008. – 63. – p. 1563 – 1565.